Parnassus Investments
CME icon

Parnassus Investments’s CME Group CME Stock Holding History

Parnassus Investments’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.3M Sell
345,432
-7,726
-2% -$2.14M 0.2% 70
2026
Q1 		$104M Sell
353,158
-150
-0% -$44.6K 0.31% 54
2025
Q4 		$96.5M Buy
353,308
+6,564
+2% +$1.78M 0.25% 56
2025
Q3 		$93.7M Buy
346,744
+32,606
+10% +$8.87M 0.22% 62
2025
Q2 		$86.6M Sell
314,138
-1,841
-0.6% -$501K 0.2% 67
2025
Q1 		$83.8M Sell
315,979
-50,848
-14% -$12.5M 0.2% 75
2024
Q4 		$85.2M Sell
366,827
-1,890,660
-84% -$435M 0.19% 79
2024
Q3 		$498M Sell
2,257,487
-2,825,125
-56% -$585M 1.06% 37
2024
Q2 		$999M Sell
5,082,612
-363,083
-7% -$75M 2.18% 15
2024
Q1 		$1.17B Sell
5,445,695
-221,689
-4% -$46.6M 2.51% 10
2023
Q4 		$1.19B Buy
5,667,384
+23,583
+0.4% +$5.03M 2.65% 10
2023
Q3 		$1.13B Sell
5,643,801
-32,879
-0.6% -$6.54M 2.76% 8
2023
Q2 		$1.05B Buy
5,676,680
+516,799
+10% +$95.5M 2.44% 11
2023
Q1 		$988M Buy
5,159,881
+916,334
+22% +$166M 2.45% 12
2022
Q4 		$714M Sell
4,243,547
-1,946,952
-31% -$338M 1.77% 25
2022
Q3 		$1.1B Buy
6,190,499
+23,339
+0.4% +$4.61M 2.85% 6
2022
Q2 		$1.26B Buy
6,167,160
+187,304
+3% +$39.7M 3.02% 5
2022
Q1 		$1.42B Sell
5,979,856
-548,913
-8% -$129M 2.88% 6
2021
Q4 		$1.49B Sell
6,528,769
-568,629
-8% -$125M 2.86% 4
2021
Q3 		$1.37B Buy
7,097,398
+951,681
+15% +$193M 2.89% 5
2021
Q2 		$1.31B Buy
6,145,717
+541,757
+10% +$114M 2.85% 5
2021
Q1 		$1.14B Buy
5,603,960
+899,549
+19% +$177M 2.78% 6
2020
Q4 		$856M Buy
4,704,411
+61,595
+1% +$10.5M 2.32% 14
2020
Q3 		$777M Buy
4,642,816
+845,927
+22% +$142M 2.41% 11
2020
Q2 		$617M Sell
3,796,889
-106,247
-3% -$19M 2.14% 16
2020
Q1 		$675M Buy
3,903,136
+346,212
+10% +$68.9M 2.81% 7
2019
Q4 		$714M Buy
3,556,924
+711,558
+25% +$146M 2.4% 9
2019
Q3 		$601M Buy
2,845,366
+41,326
+1% +$8.63M 2.18% 17
2019
Q2 		$544M Buy
+2,804,040
New +$517M 2.06% 21

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Parnassus Investments's CME Position: Q2 2026 in Review

Parnassus Investments reduced its CME Group (CME) stake by 2.2% in Q2 2026, selling an estimated $2.14M and leaving 345,432 shares worth $76.3M. The position accounts for 0.2% of the portfolio, ranked #70.

Parnassus Investments first reported a position in CME in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.49B in Q4 2021. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Parnassus Investments held 345,432 shares of CME Group worth $76.3M as of Q2 2026.
  • Parnassus Investments sold 7,726 CME Group shares in Q2 2026, an estimated $2.14M.
  • CME Group made up 0.2% of Parnassus Investments's portfolio in Q2 2026, its #70 holding.
  • Parnassus Investments first reported a position in CME Group in Q2 2019 and has held it in 29 quarters since.
  • Parnassus Investments's CME Group position peaked at $1.49B in Q4 2021.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Parnassus Investments's 13F filing for Q2 2026, filed 29 Jul 2026.